白から茶色に脂肪の切り替えは,膀がんの進行を促進します
Mingchao Gao1, Chunni Li2, Wenjie Li1
1Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Guangzhou, Guangdong, 510120, China; Guangdong Provincial Clinical Research Center for Urological Diseases, Guangdong 510120, China.
まとめ
膀がん細胞は副甲状腺ホルモン関連タンパク質 (PTHrP) を放出し,脂肪組織の茶色化を促進する. このプロセスは,自由脂肪酸の吸収と代謝の再プログラムを通じて癌の進行を促し,新しい治療目標を提供します.
科学分野:
- 腫瘍学 腫瘍学
- メタボリック研究
- 細胞生物学 細胞生物学
背景:
- 膀がんが周囲の脂肪に侵入すると,結果は悪化します.
- がんと脂肪組織のコミュニケーションのメカニズムは不明である.
研究 の 目的:
- 膀がんと周周脂肪組織との分子交響を明らかにする.
- この相互作用に関与する重要なシグナル伝達経路を特定する.
主な方法:
- 双方向的な規制ネットワークの体系的特徴.
- がん細胞-脂肪細胞共同培養に関するインビトロ研究.
- PKA阻害剤 (H89) を使用したインビボ実験.
主要な成果:
- 膀がん細胞はPTHrPを分泌し,PKAシグナル伝達を通じて脂肪組織の茶色化を誘導する.
- 脂肪組織の茶色化により,自由脂肪酸が放出され,がん細胞の増殖,侵入,転移を助長する.
- PKA阻害 (H89) は,ブラウン化を逆転させ,腫瘍の進行を弱めた in vivo.
結論:
- PTHrPは脂肪組織を茶色化させ,膀がんの進行を加速させます.
- この癌と脂肪組織の交響は,膀がんの介入のための新しい治療目標を表しています.
関連する概念動画
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Switching of BJT
897
Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
897
The Eukaryotic Promoter Region
19.0K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
The Eukaryotic Promoter Region
4.0K
4.0K
Urinary Bladder
3.6K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.6K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K


